Harvard Medical School, Endocrinology CME

Diabetes and Obesity 2025: Implications and Complications

Posted on 07/12/202507/12/2025 by NGUYEN TRONG

5 views Tags: Harvard Medical School Endocrinology CME

Comprehensive Diabetes Continuing Education to Optimize Patient Care

For those of you who provide care to individuals with—or at risk for—diabetes, managing the complex interplay of comorbidities and complications can be particularly challenging. Obesity, a major contributor to the development and progression of diabetes and many of its associated conditions, plays a critical role in patient outcomes and requires targeted, evidence-based strategies for effective management.

With these challenges in mind, Harvard Medical School faculty have developed this CME program, Diabetes and Obesity: Implications and Complications, to deliver the latest clinical updates, practice guidance, and evidence-based strategies aimed at optimizing the care of patients with diabetes and obesity.

* Date of Release: October 22–25, 2025

LEARNING OBJECTIVES

At the completion of this course, you should be able to:

Describe the pathophysiology of type 1 and type 2 diabetes, how it relates to the development and progression of key diabetes comorbidities, and how this knowledge informs prevention and treatment strategies.
Identify opportunities to improve clinical skills and office-based care systems to optimize lifestyle interventions for diabetes, obesity, and related conditions.
Describe the implications and impact of the latest evidence-based expert treatment guidelines for lifestyle, pharmacologic, and technologic management of diabetes and its comorbidities.
Recognize how evolving cardiovascular and renal outcomes trial data for antidiabetes medications can be applied to the prevention, diagnosis, and treatment of diabetes-related comorbidities.
Apply current preventive, diagnostic, and therapeutic approaches to managing diabetes-related complications affecting the eyes, nerves, peripheral vascular system and foot, liver, bone, and hypoglycemia, including care considerations for special populations such as older adults, pregnant patients, and hospitalized individuals.
Identify and overcome common clinical practice barriers related to patients, healthcare providers, and healthcare systems.
Communicate effectively with individuals with diabetes, their families, and healthcare team members to support a collaborative, patient-centered approach to health promotion, disease prevention, and chronic disease management.

DIABETES AND OBESITY: IMPLICATIONS AND COMPLICATIONS 2025

ALL FULLHD VIDEOS & PRESENTATION PDFS

$150 ~~$200~~

BUY NOW!

0 0 votes

Article Rating

HARVARD DIABETES AND ITS COMPLICATIONS 2025 TOPICS

Day 1. Wednesday, October 22, 2025

I. COMPREHENSIVE APPROACHES TO OBESITY: BLUNTING ITS IMPACT

1. Complementary & Alternative Medicines for Weight Loss, Diabetes and Life – Frank J. Domino, MD

2. Tailoring Nutrition for Success: Personalized Strategies for Weight Management – Jody Dushay, MD, MMSc

3. Burning Clinical Question: I Want to Start a GLP-1 RA, but I’m Worried About Muscle Loss – Jody Dushay, MD, MMSc

4. Physiology of Exercise – Maria Vamvini, MD

5. Personalizing the Exercise Prescription: An Office-Based Approach – Edward M. Phillips, MD

II. MEDICAL AND SURGICAL MANAGEMENT OF OBESITY

1. Pharmacologic Management of Obesity: Rapidly Expanding Options – Osama Hamdy, MD, PhD, FACE

2. Modern Surgical Treatment of Obesity: Techniques and Patient Outcomes – Souheil W. Adra, MD, FACS, ABOM

III. UPDATES ON THE MEDICAL MANAGEMENT OF DIABETES

1. Beyond Metformin: Navigating and Applying the New Guidelines and Reducing Cardiovascular Risk – Martin J. Abrahamson, MD, FACP, FRCP (London)

2. Newer Insulins and How to Use Them: A Comprehensive Primer – Richard S. Beaser, MD

3. Burning Clinical Question: How Can I Learn to Count Carbohydrates in 10 Minutes? – Gillian Arathuzik, RD, LDN, CDCES

4. Burning Clinical Question: My Patient with Type 2 Diabetes Just Had a Stent – Do I Need to Change Their Medications? – Martin J. Abrahamson, MD, FACP, FRCP (London)

Day 2. Thursday, October 23, 2025

I. MACROVASCULAR DISEASE AND DIABETES

1. Managing Hypertension in People with Diabetes: Evolving Clinical Challenges – Melanie P. Hoenig, MD

2. Managing Dyslipidemia in Diabetes: Individualizing Treatment Options – Om P. Ganda, MD, MBBS, MACE

3. KEYNOTE: Microbiome (The Second Human Genome): What Shapes It and How It Shapes Us – Sanjiv Chopra, MD, MACP, FRCP (London)

II. CARDIOVASCULAR DISEASE AND DIABETES

1. Management of Acute Coronary Syndromes and Chronic Cardiovascular Disease in Patients with Diabetes – Donald E. Cutlip, MD

2. Diabetes and Heart Failure: Update on Management – A. Reshad Garan, MD, MS, FACC

3. Common Cardiovascular Tests and Their Optimal Interpretation – Michael C. Gavin, MD, MPH, FACC

III. MISCELLANEOUS

1. Metabolic-Associated Steatotic Liver Disease (MASLD) – Sanjiv Chopra, MD, MACP, FRCP (London)

2. Screening, Prevention, and Early Treatment of Type 1 Diabetes – Jason L. Gaglia, MD, MMS

Day 3. Friday, October 24, 2025

I. EMERGING TECHNOLOGIES AND CHALLENGES IN DIABETES

1. Tech-Enabled Diabetes Care: Tools and Innovations for Better Outcomes – Anne Peters, MD

2. Burning Clinical Question: How Do I Start Insulin in a Person Who Is Not Well Controlled on Non-Insulin Medications? – Richard S. Beaser, MD

3. Overcoming Hypoglycemia: Prevention and Treatment in Modern Diabetes Care – Mary-Elizabeth Patti, MD

4. KEYNOTE: The Expanding Universe of GLP-1 Medicines – Daniel J. Drucker, FRS, FRCPC, OC

5. Diabetes in Older Adults: Unique Perspectives in This Important Population – Medha N. Munshi, MD

6. Inpatient Management of Diabetes: Strategies and Transition to the Outpatient Setting – Zachary H. Taxin, MD

7. Future Therapies for Diabetes – Alan C. Moses, MD, FACP

8. Strategies to Promote Equity in Diabetes Care – Leonor Fernandez, MD

9. Burning Clinical Question: How Do I Transition to a Full Basal/Bolus Insulin Program? – Richard S. Beaser, MD

10. Burning Clinical Question: How Do I Interpret My Patient’s CGM Data? – Martin J. Abrahamson, MD, FACP, FRCP (London)

Day 4. Saturday, October 25, 2025

I. MULTIDISCIPLINARY CASE WORKSHOP

1. Multidisciplinary Case Workshop and Panel Discussion – Martin J. Abrahamson, MD; Richard S. Beaser, MD; Melanie P. Hoenig, MD; Om P. Ganda, MD; Donald E. Cutlip, MD

II. SPECIAL POPULATIONS AND MICROVASCULAR COMPLICATIONS

1. Burning Clinical Question: My Patient with Type 2 Diabetes Wants to Become Pregnant – How Should I Counsel Her? – Florence M. Brown, MD

2. Burning Clinical Question: My Patient with Type 1 Diabetes Just Found Out She Is Pregnant – What’s the Optimal Management? – Florence M. Brown, MD

3. KEYNOTE: Artificial Intelligence in Medicine – Adam M. Rodman, MD, MPH

4. Retinopathy in Diabetes: Innovations in Screening and Treatment – Deborah K. Schlossman, MD

5. Treatment of Renal Disease: Guidance to Blunt the Impact and Slow the Progression – Melanie P. Hoenig, MD

6. Evaluating and Treating Neuropathies of Diabetes: 2025 Updates – Patricia E. Greenstein, MBBCh

III. THE DIABETIC FOOT

1. Preserving the Health of the Diabetic Foot: Practical Approaches – John M. Giurini, DPM

2. Peripheral Vascular Disease in Diabetes: Innovations and Best Practices – David R. Campbell, MD, FRCS, FACS